ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2022
Benefits of nirmatrelvir-ritonavir remain unproven for some populations.
Emily G McDonald et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.